Live Breaking News & Updates on Mersana Therapeutics Daily

Stay updated with breaking news from Mersana therapeutics daily. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Sees Significant Decline in Short Interest

Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) saw a significant drop in short interest during the month of May. As of May 15th, there was short interest totalling 8,990,000 shares, a drop of 17.7% from the April 30th total of 10,920,000 shares. Based on an average trading volume of 2,150,000 shares, the days-to-cover ratio […] ....

Robertw Baird , Jpmorgan Chase Co , Merck Kgaa , Asana Biosciences , Acadian Asset Management , Janssen Biotech Inc , Russell Investments Group Ltd , Mersana Therapeutics Company Profile , Walleye Trading , Mersana Therapeutics Inc , Pricet Rowe Associates Inc , Merck Kga , Vanguard Group Inc , Mersana Therapeutics , Get Free Report , Truist Financial , Asset Management , Russell Investments Group , Investments Group , Therapeutics Trading Down , Janssen Biotech , Ares Trading , Mersana Therapeutics Daily ,

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) have earned an average rating of “Moderate Buy” from the seven ratings firms that are covering the company, MarketBeat reports. Two analysts have rated the stock with a hold rating and five have given a buy rating to the company. The average 1 year price […] ....

Robertw Baird , Victory Capital Management Inc , Jpmorgan Chase Co , Russell Investments Group Ltd , Sg Americas Securities , Nisa Investment Advisors , Mersana Therapeutics Company Profile , Janssen Biotech Inc , Asana Biosciences , Mersana Therapeutics Inc , Merck Kgaa , Merck Kga , Mersana Therapeutics , Get Free Report , Capital Management , Investment Advisors , Investments Group , Get Free , Janssen Biotech , Ares Trading , Mersana Therapeutics Daily ,

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Shares of Mersana Therapeutics, Inc. (NASDAQ:MRSN – Get Free Report) have received a consensus recommendation of “Moderate Buy” from the seven ratings firms that are covering the stock, Marketbeat.com reports. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating on the company. The average 12-month price […] ....

Robertw Baird , Victory Capital Management Inc , Janssen Biotech Inc , Pricet Rowe Associates Inc , Mersana Therapeutics Inc , Merck Kga , Jpmorgan Chase Co , Asana Biosciences , Harbor Capital Advisors Inc , Russell Investments Group Ltd , Nisa Investment Advisors , Merck Kgaa , Mersana Therapeutics , Get Free Report , Investments Group , Capital Advisors , Capital Management , Investment Advisors , Get Free , Janssen Biotech , Ares Trading , Mersana Therapeutics Daily ,

Mersana Therapeutics (NASDAQ:MRSN) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Mersana Therapeutics (NASDAQ:MRSN) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Janssen Biotech Inc , Merck Kgaa , Mersana Therapeutics Company Profile , Asana Biosciences , Merck Kga , Mersana Therapeutics Inc , Jpmorgan Chase Co , Mersana Therapeutics , Get Free Report , Janssen Biotech , Ares Trading , Mersana Therapeutics Daily ,